Search results for "Guidelines."

showing 10 items of 611 documents

Guidelines and Current Assessment of Health Care Responsibility in Italy

2020

Stefania Zerbo, Ginevra Malta, Antonina Argo Department of Health Promotion, Maternal and Child Care, “G. D’Alessandro”, Legal Medicine Section, University of Palermo, Palermo, ItalyCorrespondence: Stefania ZerboDepartment of Health Promotion, Maternal and Child Care, “G. D’Alessandro”, Legal Medicine Section, University of Palermo, via del Vespro N. 129, Palermo 90127, ItalyTel +39 33 3725 0209Fax +39 09 1655 3203Email stefania.zerbo@unipa.itAbstract: Clinical guidelines are a potential tool for improving the effectiveness and quality of healthcare, decreasing variability in clinical practice, and preventing adverse events. In the…

Risk Management and Healthcare PolicyGelli-Bianco lawclinical guidelinesSettore MED/43 - Medicina LegaleCommentarymedical malpracticeclinical guidelines health care liability medical malpractice Gelli-Bianco lawliabilityhealth carehumanitiesRisk Management and Healthcare Policy
researchProduct

Guideline-adherence and perspectives in the acute management of unstable angina - Initial results from the German chest pain unit registry.

2015

Abstract Background We investigated the current management of unstable angina pectoris (UAP) in certified chest pain units (CPUs) in Germany and focused on the European Society of Cardiology (ESC) guideline-adherence in the timing of invasive strategies or choice of conservative treatment options. More specifically, we analyzed differences in clinical outcome with respect to guideline-adherence. Method Prospective data from 1400 UAP patients were collected. Analyses of high-risk criteria with indication for invasive management and 3-month clinical outcome data were performed. Guideline-adherence was tested for a primarily conservative strategy as well as for percutaneous coronary interventi…

Risk profilingMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentMedizinCardiologyChest painPatient AdmissionPercutaneous Coronary InterventionRisk FactorsInternal medicineGermanymedicineHumansAcute managementAngina UnstableProspective StudiesRegistriesAgedGuideline adherenceUnstable anginabusiness.industryPercutaneous coronary interventionDisease ManagementGuidelineMiddle Agedmedicine.diseaseConventional PCIEmergency medicinePractice Guidelines as TopicPhysical therapyCardiologyGuideline Adherencemedicine.symptombusinessCardiology and Cardiovascular MedicineHospital UnitsJournal of cardiology
researchProduct

[Recommendations for end-of-life care in patients with chronic obstructive pulmonary disease].

2009

Over the last 20 years, advances in the treatment of patients with chronic obstructive pulmonary disease (COPD) have improved survival even among patients in the most advanced stages of the disease, such as those requiring domiciliary oxygen therapy.1,2 This improvement—in principle a positive development—has given rise to considerable clinical problems associated with the establishment of a therapeutic ceiling and the difficulty of determining prognosis in some of these patients. In this situation, the clinician should consider introducing palliative care, that is, care aimed at improving symptom control, communication, physical activity, and emotional support, in order to achieve the best…

Riskmedicine.medical_specialtyPalliative careAttitude to DeathAttitude of Health PersonnelHealth PersonnelDecision MakingContext (language use)DiseaseAnxietyPulmonary Disease Chronic ObstructiveQuality of life (healthcare)Intensive careHealth caremedicineHumansTerminally IllIntensive care medicineCOPDPhysician-Patient RelationsTerminal Carebusiness.industryDepressionGeneral Medicinemedicine.diseasePrognosisDyspneaPatient RightsCaregiversSpainPractice Guidelines as TopicbusinessAdvance DirectivesEnd-of-life careArchivos de bronconeumologia
researchProduct

Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma

2019

AIMS: Mobile Airways Sentinel NetworK (MASK) belongs to the Fondation Partenariale MACVIA-LR of Montpellier, France and aims to provide an active and healthy life to rhinitis sufferers and to those with asthma multimorbidity across the life cycle, whatever their gender or socio-economic status, in order to reduce health and social inequities incurred by the disease and to improve the digital transformation of health and care. The ultimate goal is to change the management strategy in chronic diseases. METHODS: MASK implements ICT technologies for individualized and predictive medicine to develop novel care pathways by a multi-disciplinary group centred around the patients. STAKEHOLDERS: Incl…

SENTINEL NETWORKAllergyRespiratory Medicine and AllergyReviewWORLD-HEALTH-ORGANIZATIONDiseaseRhinitis.App; Asthma; Care pathways; DG Santé; MASK; mHealth; Rhinitis0302 clinical medicineQUALITY-OF-LIFEPRECISION MEDICINEDG SantéHealth careMedicine and Health SciencesGRADING QUALITYImmunology and AllergyMedicinemHealthRinitisLungmedicin och allergiRhinitis0303 health sciencesThe MASK study groupPublic sectorApp ; Asthma ; Care pathways ; MASK ; mHealth ; Rhinitis ; DG SanteMOBILE TECHNOLOGY3. Good healthALLERGIC RHINITISCHRONIC RESPIRATORY-DISEASESRinitemHealthCare pathwaysEUROPEAN SYMPOSIUMCLINICAL-PRACTICE GUIDELINESLife Sciences & BiomedicinePulmonary and Respiratory Medicinemedicine.medical_specialtyMASKImmunologySettore MED/10 - Malattie Dell'Apparato RespiratorioPredictive medicine03 medical and health sciencesQuality of life (healthcare)App -MASKAsma030304 developmental biologyAsthmaARIAScience & TechnologyCare pathwaybusiness.industryChange managementCorrectionDG SanteRC581-607medicine.diseaseAsthma030228 respiratory systemApp; Asthma; Care pathways; DG Santé; MASK; mHealth; Rhinitis; Immunology and Allergy; Immunology; Pulmonary and Respiratory MedicineFamily medicineImmunologic diseases. AllergybusinessApp[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
researchProduct

Analisi delle evidenze epidemiologiche sui fattori di rischio indoor per malattie respiratorie e allergiche nelle strutture scolastiche [Analysis of …

2012

Il diritto a respirare aria sana nelle scuole è stato sancito già nell’anno 2001 in un documento dell’European Federation of Asthma and Allergy Associations che ha evidenziato scarsa attenzione e assenza di direttive specifiche dell’Unione Europea relativamente agli effetti sulla salute da inquinamento dell’aria nelle scuole, ed è sostenuto dal numero enorme di bambini e ragazzi che frequentano le aule scolastiche. Negli ultimi anni, a livello europeo si è sviluppato un sempre crescente interesse nei confronti dell’effetto della qualità dell’aria dell’indoor scolastico (IAQ) sulla salute dei ragazzi, e sono stati avviati numerosi progetti di ricerca internazionali mirati, appunto, a determi…

SchoolSampling StudieEvidence-Based MedicineAdolescentInternational CooperationRisk FactorGuidelines as TopicEnvironmental ExposureEuropePrimary PreventionItalyAir Pollution IndoorChild PreschoolRespiratory HypersensitivityProgram DevelopmentSocietieChildHuman
researchProduct

Linee guida per un protocollo all’accessibilità della città storica di Palermo

2021

Il progetto I-Access nasce dalla precisa volontà di sperimentare un nuovo modello di approccio, utilizzando l’accessibilità come chiave interpretativa e progettuale innovativa per gli interventi nei centri storici, così come oggi si presentano a partire dai nuovi sce- nari sociali e culturali configuratisi a seguito della seconda guerra mondiale, e poi strut- turati in seguito alla ricostruzione post-bellica e al progressivo riconoscimento internazionale quale patrimonio culturale dell’umanità siglato per l’intero centro storico di La Valletta nel 1980 e per l’itinerario arabo-normanno per la città di Palermo nel 2015. Tali riconoscimenti diventano un rinnovato punto di partenza per mantene…

Settore ICAR/13 - Disegno IndustrialeSettore ICAR/19 - RestauroI-Access project Palermo Valletta historic centers cultural accessibility guidelines protocolI-Access project Palermo Valletta centri storici accessibilità culturale linee guida protocollo
researchProduct

Recognizing the Emergent and Submerged Iceberg of the Celiac Disease: ITAMA Project-Global Strategy Protocol.

2022

Coeliac disease (CD) is frequently underdiagnosed with a consequent heavy burden in terms of morbidity and health care costs. Diagnosis of CD is based on the evaluation of symptoms and anti-transglutaminase antibodies IgA (TGA-IgA) levels, with values above a tenfold increase being the basis of the biopsy-free diagnostic approach suggested by present guidelines. This study showcased the largest screening project for CD carried out to date in school children (n=20,000) aimed at assessing the diagnostic accuracy of minimally invasive finger prick point-of-care tests (POCT) which, combined with conventional celiac serology and the aid of an artificial intelligence-based system, may eliminate t…

Settore INF/01 - Informaticaintestinal biopsypoint-of-care testanti-transglutaminaseguidelinesnegative predictive valueartificial intelligenceESPGHANmucosal depositsPediatricscoeliac diseaseSettore FIS/07 - Fisica Applicata(Beni Culturali Ambientali Biol.e Medicin)Pediatric reports
researchProduct

[Deciding in conditions of uncertainty: the Delphi method and its use in the formulation of guidelines].

2001

The purpose of this paper is to analyze one of the most powerful tools in the decision-making under conditions of uncertainty, the Delphi method, and to verify the related interest of scientific world, particularly, for formulation of guidelines. The method combines the expert opinion preventing biases due to institutional role, status or dominant personality. In the text we explain the methodology and the steps through which it is possible to realize the consensus; we schematized in a didactic manner all the phases for an operational approach of the reader. The search by the most diffused biomedical database (Medline) individualized 623 citations, 7 of which are guidelines (3 of remarkable…

Settore MED/09 - Medicina InternaDelphi TechniqueMEDLINEDecision TreeDecision TreesDelphi methodPlanning techniquesInformation Storage and RetrievalGuidelines as TopicHealth planning guidelineRecenti progressi in medicina
researchProduct

Use of ICS in COPD: From Blockbuster Medicine to Precision Medicine

2017

Chronic obstructive pulmonary disease (COPD) is a major cause of mortality worldwide, whose burden is expected to increase in the next decades, because of numerous risk factors, including the aging of the population. COPD is both preventable and treatable by an effective management including risk factor reduction, prevention, assessment, and treatment of acute exacerbations and co-morbidities. The available agents approved for COPD treatment are long-acting or ultra-long-acting β2-agonists (LABAs) and long-acting muscarinic antagonists (LAMAs) bronchodilators, as well as inhaled corticosteroids (ICS) in combination with LABAs. ICS use has been restricted only to selected COPD patients by th…

Settore MED/10 - Malattie dell'Apparato RespiratorioAlternative medicineCOPD; drivers; inhaled corticosteroids; prescribing; Pulmonary and Respiratory MedicineCOPD; drivers; inhaled corticosteroids; prescribingAdrenal Cortex HormonePulmonary Disease Chronic Obstructive0302 clinical medicineAdrenal Cortex HormonesDrug Combination030212 general & internal medicinePractice Patterns Physicians'Precision Medicineeducation.field_of_studyCOPDEvidence-Based MedicineprescribingdriversBronchodilator AgentsDrug CombinationsMuscarinic AntagonistPractice Guidelines as TopicGuideline AdherenceHumanAdrenergic beta-2 Receptor AgonistPulmonary and Respiratory Medicinemedicine.medical_specialtydriverPopulationSocio-culturaleInhaled corticosteroidsMuscarinic Antagonistsinhaled corticosteroid03 medical and health sciencesAdministration InhalationmedicineHumansCOPDMedical prescriptionRisk factorIntensive care medicineeducationAdrenergic beta-2 Receptor AgonistsBronchodilator AgentPrimary Health Carebusiness.industryPrecision medicinemedicine.disease030228 respiratory systemObservational studyinhaled corticosteroidsbusiness
researchProduct

2016 WHO GLOBAL GUIDELINES FOR THE PREVENTION OF SURGICAL SITE INFECTION: A NEW STEP TO IMPROVE PATIENT'S SAFETY BEFORE, DURING AND AFTER SURGERY

2017

Surgical site infection (SSI) are among the most preventable health-care-associated infections and are a substantial burden to health-care systems and service payers worldwide in terms of patient morbidity, mortality, and additional costs. SSI prevention is complex and requires the integration of a range of measures before, during and after surgery. No international guidelines are available and incosistencies in the interpretations of evidence and recommendations of national guidelines have been identified. Given the burden of SSI worldwide, the numerous gaps in evidence-based guidance, and the need for standardisation and a global approach, WHO decided to prioritise the development of evid…

Settore MED/18 - Chirurgia Generalewound surgical infections guidelines patient safety
researchProduct